Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

NACompletedINTERVENTIONAL
Enrollment

1,191

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2018

Conditions
Stable AnginaUnstable AnginaAcute Myocardial Infarction
Interventions
DEVICE

Amphilimus Eluting Stent (CRE8)

Sirolimus formulated coronary eluting stent

Trial Locations (23)

3600

Ziekenhuis Oost Limburg, Genk

6020

Medizinische Universität Innsbruck, Innsbruck

10154

ASL TO2 Torino Nord - Ospedale S. Giovanni Bosco, Torino

12038

A.S.L. CN1 - Ospedale SS Annunziata di Savigliano, Savigliano

17100

Azienda Sanitaria Locale n°2 Savonese - Ospedale San Paolo, Savona

20089

Istituto Clinico Humanitas IRCCS, Rozzano

20131

Istituto Clinico Città Studi, Milan

20132

Fondazione San Raffaele del Monte Tabor, Milan

20138

Centro Cardiologico Monzino, Milan

35128

Azienda Ospedaliera di Padova, Padua

52100

Azienda USL 8 Arezzo - Ospedale San Donato, Arezzo

61100

Azienda Ospedaliera S. Salvatore, Pesaro

80122

Clinica Mediterranea SpA, Napoli

80131

"Azienda Ospedaliera Universitaria Federico II", Napoli

90127

"Azienda di Rilievo Nazionale e di Alta Specializzazione - Presidio Ospedaliero Civico e Benfratelli", Palermo

00161

Azienda Policlinico Umberto I, Roma

1091 AC

Onze Lieve Vrouwe Gasthuis, Amsterdam

5623 EJ

Catharina Ziekenhuis, Eindhoven

3435CM

St. Antonius Ziekenhuis, Nieuwegein

5042 AD

TweeSteden Ziekenhuis, Tilburg

0027

Oslo University Hospital - Rikshospitalet, Oslo

20-954

Klinika Kardiologii SPSK4 w Lublinie, Lublin

61-848

Szpital Kliniczny Przemienienia Panskiego, Poznan

All Listed Sponsors
lead

CID - Carbostent & Implantable Devices

INDUSTRY

NCT01556126 - Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population | Biotech Hunter | Biotech Hunter